Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SM (ADAR-related conditions)
- Development stage
- Preclinical
- Lead developer
- SoftMining
- Modality
- Small Molecules
01
Overview
SM (ADAR-related conditions) is an early-stage drug discovery program developed by SoftMining, an Italian biotechnology company that utilizes artificial intelligence for drug design. The program focuses on the development of therapeutics for conditions associated with the dysregulation of Adenosine Deaminase Acting on RNA (ADAR) enzymes. ADAR enzymes are responsible for A-to-I RNA editing, a process that, when aberrant, is linked to rare genetic disorders such as Aicardi-Goutières Syndrome (AGS), as well as various autoimmune diseases and cancers. The program is currently in the early discovery or preclinical phase, aiming to identify small molecule modulators of ADAR activity using SoftMining's computational platform.
- Other names
- SM (ADAR-related)
02
Targets
ADAR (Adenosine deaminases acting on RNA (ADAR) family)
Beyond the preview
Go deeper on SM (ADAR-related conditions).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SM (ADAR-related conditions).